Next Generation Partners

Healthcare and life sciences in Sweden

Cirio Advokatbyrå AB

The life science, healthcare, and food team at Cirio Advokatbyrå AB handles a full spectrum of mandates, from complex regulatory matters to disputes. In particular, the group is known for its work within digital health, alongside capital raisings in the life sciences sector. Practice head Per Hedman is well-regarded for his work in transactions, including cross-border M&A and venture capital investments, and has extensive experience in the pharma, medtech, and biotech sectors. Working alongside him is Hanna Tilus, who has expertise in intellectual property, regulatory, and technology law, and who also advises clients across pharma and health care.

Praxisleiter:

Per Hedman


Weitere Kernanwälte:

Hanna Tilus; Jessica Grönberg


Referenzen

‘For me, they are the obvious choice for any topic that requires a deeper understanding of the life science industry. Whether it is deal terms, supply agreements, or IP, I feel confident they can handle it excellently. As their service is always excellent, I rely on them for much more.’

‘I work mainly with Per Hedman. He cares about building and maintaining a long-term relationship in a way that makes it very easy to address complicated matters whenever they arise. He combines his own depth of expertise and that of his network with a great ability for pragmatic discussion and problem-solving. His associates are always on excellent terms as well.’

‘Cirio’s healthcare and life sciences team combines strong sector expertise with pragmatic and commercially relevant advice. They are collaborative, responsive, and solution-oriented, which makes them stand out compared to other firms. Their ability to navigate complex, multi-stakeholder matters and adapt flexibly to client needs is a key strength.’

Kernmandanten

Takeda


10x Genomics


Gesynta Pharma


Elypta


Boule Diagnostics


Hadean Ventures


Karolinska Development


Intervacc


Scandinavian Biopharma


Sprint Bioscience


Symcel


Annexin Pharmaceutcials


AlzeCure Pharma


Anocca


FrostPharma


Industrifonden


Highlight-Mandate


  • Advised Alvotech on the listing of its shares on Nasdaq Stockholm and a SEK 750 million private placement.
  • Advised Gesynta Pharma on its SEK 347 million Series B round involving prominent investors, financing a Phase 2 clinical trial of vipoglanstat.
  • Advises Intervacc on life science legal matters and recently advised on a SEK 225 million guaranteed rights issue, completed in a challenging fundraising climate and requiring consideration of the Prospectus Regulation and the new Foreign Direct Investment Act.

Mannheimer Swartling

Mannheimer Swartling‘s healthcare and life sciences team remains active, advising on a wide range of regulatory, dispute, and M&A matters within the space. Recently, the team has been focusing on digital compliance matters and market access models. Practice lead Camilla Appelgren is frequently engaged in licensing, clinical trials, and complex data protection issues for pharmaceutical companies, research institutions, and investors. Peter Nilsson Torres is a key contact for commercial and compliance matters, and Emmie Montgomery regularly represents clients in contentious regulatory matters.

Praxisleiter:

Camilla Appelgren


Weitere Kernanwälte:

Peter Nilsson Torres; Emmie Montgomery


Referenzen

‘The team is highly knowledgeable and experienced on pharma price and reimbursement questions and knows the processes and practices of competent authorities. They are easy to work with and very accommodating to meet the sometimes strict timelines.’

‘Camilla Appelgren and Emmie Montgomery stand out from the team as highly knowledgeable individuals. They support the client in finding the best strategy for achieving the goals.’

‚Peter Nilsson Torres has a huge knowledge and he is very committed, but he also demonstrated business acumen but understanding immediately the business needs and proposing business-oriented solutions. Really exceptional and from business highly appreciated.’

Kernmandanten

Bristol-Myers Squibb (BMS)


Swedish Orphan Biovitrum AB (publ) (Sobi)


AbbVie AB


Inceptua S.A.


Lipum AB (publ)


Capio AB


Capio S:t Görans Sjukhus AB


Janssen-Cilag


Amgen


Humana AB (publ)


Impilo


KKR


EQT Healthcare Growth


Novartis


BioArctic


Bayer


Pfizer AB


Anocca


Astellas Pharma A/S


Gilead Sciences Sweden AB


Nestlé Sverige AB


Highlight-Mandate


  • Advised KKR on the acquisition of Karo Healthcare to deliver “Smart choices for everyday healthcare” with a vast product portfolio (including cosmetics, medical devices, pharmaceuticals, and foods) – from EQT.
  • Advised EQT on its agreement to acquire a majority stake of the shares in Europa Biosite from Adelis Equity.
  • Assisting BMS regularly with regulatory and commercial matters.

Setterwalls

With a particular strength in patent disputes, the team at Setterwalls is known for its deep regulatory knowledge and comprehensive transactional offering. The firm has extensive experience within the MedTech sector, specifically, often engaged to advise on a range of emerging and innovative issues. Per Lidman leads the life sciences group, where he brings experience in intellectual property and commercial transactions. In regard to regulatory issues, Helena Nilsson is a key contact, being frequently engaged in a range of authorisations and reimbursement issues. Martin Levinsohn is highly recommended for his work in disputes relating to pharma and biotech.

Praxisleiter:

Per Lidman


Weitere Kernanwälte:

Helena Nilsson;  Martin Levinsohn; Jakob Losell;  Anja Siöstedt


Referenzen

‘Setterwalls is action action-oriented and very professional company that has a broad range of expertise.’

‘Curious and engaged team staffed appropriately to the task at hand. ’

‘Helena Nilsson is very knowledgeable about us as a client, about the regulatory framework we operate in, and the legal context for the industry. ’

Highlight-Mandate


Vinge Advokatfirman KB

With expertise in multijurisdictional patent litigation, the team at Vinge Advokatfirman KB advises on a range of health care and life sciences mandates, and has experience working on financing, regulatory matters, and complex M&A transactions. For intellectual property matters, Håkan Borgenhäll is a key contact; he is frequently engaged in a range of trademark and marketing matters. Likewise, Malin Malm Waerme brings similar expertise, working for multinational enterprises, while Malin Ohlin is well-regarded for her commercial work within the sector. Christoffer Nordin is regularly engaged in regulatory matters, including product liability and product safety. He co-heads the team with Åsa Hellstadius.

Praxisleiter:

Åsa Hellstadius; Christoffer Nordin


Weitere Kernanwälte:

Håkan Borgenhäll; Malin Malm Waerme; Malin Ohlin


Referenzen

‘Strong knowledge of the life sciences sector, strong firm, and strong partners.’

‘Hakan Borgenhall is a highly experienced practitioner.‘

‚Malin Malm Waerme is extremely helpful and easy to work with.’

Kernmandanten

Eli Lilly and Company


Bridgepoint Growth


Fidelio Capital


Recipharm AB (publ)


Atlas Antibodies AB


Tamro AB


Vimian Group AB (publ)


Corline Biomedical AB (publ)


Medivir AB (publ)


Xspray Pharma AB (publ)


Hansa Biopharma AB


Calliditas Therapeutics AB (publ)


Oncopeptides AB (publ)


BioGaia AB (publ)


Nanoform Finland Plc


Medicover AB (publ)


Järven Plast & Smide Aktiebolag


Cinclus Pharma AB


A3P Biomedical


Healthcap


Attgeno AB


Biotage AB


Thermo Fischer Scientific Inc


Xvivo Perfusion AB


Merck Sharp & Dohme (“MSD”)


Takeda Pharmaceutical International Inc


Takeda Pharmaceuticals U.S.A. Inc.


Ambea AB


Apotea AB


Highlight-Mandate


  • Representing Merck Sharp & Dohme in a dispute where KRKA has initiated an invalidity action against one of MSD’s supplementary protection certificates (“SPC”) for its anti-diabetic drug Janumet®.
  • Advising Takeda on three interrelated SPC disputes concerning an ADHD treatment, including an infringement case against Sandoz and two validity actions involving STADA and Teva.

Advokatfirman Delphi

The team at Advokatfirman Delphi routinely handles a range of capital market and health data mandates within the life sciences and healthcare sector. Alongside this, the team has experience in a broad array of transactions, public procurement, and IP matters, where they advise large and medium-sized companies. Elisabeth Eklund co-heads the team, providing a wealth of experience in competition law and regulatory matters within the life sciences sector. Leading the practice alongside her, Mats Dahlberg is a key contact for capital market transactions, such as IPOs and spin-offs.

Praxisleiter:

Elisabeth Eklund; Mats Dahlberg


Weitere Kernanwälte:

Magnus Berterud; Martin Bogg


Referenzen

‘The team is highly responsive and demonstrates a solid understanding of the external environment in healthcare. They have valuable contacts with key stakeholders, which enhances their effectiveness. Additionally, their good availability makes collaboration smooth and reliable. Overall, a professional and well-connected firm!’

‘Straightforward communication, driven by facts, and professional.’

‘Elisabeth Eklund, Magnus Berterud, and Martin Bogg are outstanding, knowledgeable, and service-minded. ’

Kernmandanten

Attendo Sverige AB


CycleZyme AB (publ)


Enorama Pharma AB (publ)


ForMotion AB


Hamlet BioPharma AB


Johnson & Johnson Innovative Medicine


Lindex Sverige AB


Malmhill


NordicInfu Care AB


Pareto Securities


Paxman AB


Pharmacosmos A/S


Phase Holographic Imaging PHI AB (publ)


PolarCool AB (publ)


ProstaLund AB (publ)


Signet Healthcare Partners


Simris Group AB (publ)


Suicide Zero


Highlight-Mandate


  • Represented Lindex Sverige AB in a dispute against Essity Hygiene and Health AB, a global leading hygiene and health company. The dispute regarded Lindex’s period underwear, where Essity claimed that these should be classified as medical devices under the EU Medical Device Regulation (MDR) and require CE-marking.
  • Represents an international pharmaceutical company in a pending investigation carried out by the Swedish Competition Authority regarding alleged abuse of a dominant position due to an alleged excessive price.
  • Assisted Signet Healthcare Partners in connection with its investment in NorthX Biologics, a leading Nordic biopharmaceutical contract development and manufacturing organization (CDMO).

Advokatfirman Cederquist KB

With a solid track record in a range of transactional work in the sector, Advokatfirman Cederquist KB‘s life sciences and healthcare team brings a multi-disciplinary approach to the practice, allowing expertise in regulatory disputes, IP matters, and data privacy work. Regarding IP and marketing matters, team head Malin Allard is a key contact, as she is frequently engaged in a range of IPR infringements and technology licensing arrangements. Fellow practice head Annika Blomqvist is well placed to advise on a range of regulatory matters, as well as drafting commercial contracts for clinical studies.

Praxisleiter:

Malin Allard; Annika Blomqvist


Weitere Kernanwälte:

Henrik Lindstrand; Johanna Linder


Referenzen

‘The Cederquist team demonstrates a high level of expertise. They are available and highly responsive to assist when we need them. This team functions as a strategic partner to us and delivers innovative and effective solutions to novel and complex matters. Their expertise spans from advising on all regulatory aspects relevant to our operations to representing us in regulatory disputes in Swedish courts.‘

‚Annika Blomqvist is a go-to for high-stakes regulatory disputes — combining deep sector knowledge with innovative advocacy. She translates complex regulatory frameworks into clear, actionable litigation strategies.‘

‘All positive results come from Annika Blomqvist and her team. Annika is competent, thorough, reliable, and available to you as a client. In the case we worked with her ability and strive to get the right wording in every detail of the legal issues, but also in any correspondence between us, the executives, and at the municipality contributed to getting a successful outcome.’

Kernmandanten

Ahlén Medical Nordic AB (SAM Nordic)


Ottobock Care Sverige AB


Vården Online Sverige AB


Yrkesföreningar För Fysisk Aktivitet (Yfa)


Vision Healthcare


Ayd AB


Carico AB


Highlight-Mandate


  • Advised Vision Healthcare in connection with the acquisition of Svenskt Kosttillskott, a leading Swedish e-commerce player for health and nutrition products.
  • Advising a pharmaceutical company in relation to commercial contracts, regulatory aspects, and regulatory disputes.
  • Advising a company within the care sector in a contract dispute with a public authority.

Hammarskiöld

Advising a broad range of clients from biopharma companies to healthcare providers, the healthcare and life sciences team at Hammarskiöld has experience providing regulatory support; frequently engaged in matters relating to EU legislative acts. Practice head Malin Von Heideken regularly engaged in commercial disputes against government agencies before the Administrative Courts in Sweden. Working alongside her is Timothy Mjällby, who is well-regarded for his regulatory and compliance work.

Praxisleiter:

Malin von Heideken


Weitere Kernanwälte:

Timothy Mjällby


Referenzen

‘Quick, accessible, and practical advice. ’

‘Deep knowledge about life science business practice and business terms/deals. Very effective and cost-efficient.’

‘Hammarskiöld’s professionalism and competence, combined with a client-focused approach, are factors that make it very easy to recommend them. More impressive is their ability to knowledgeably and proficiently navigate the wide array of research-related contracts that they have assisted with.’

Kernmandanten

Neogap Therapeutics AB


Sleip AI AB


CellcolabsAB


Asker Healthcare Group AB (OneMed)


Devyser Diagnostics Group


Sigrid Therapeutics AB


PsomriHolding AB


OrifarmGroup


LF Research Foundation


Thermo Fisher Scientific


Tietoevry


Highlight-Mandate


  • Advised Neogap Therapeutics AB in relation to an extensive collaboration agreement.
  • Advised Sleip AI AB in connection with its ongoing international expansion, providing legal advice on a range of regulatory and compliance matters.
  • Advises LF Research Foundation in relation to a broad range of contractual and regulatory matters within the life sciences sector.

Advokatfirman Lindahl KB

Handling an array of matters across the life sciences and health care space, the team at Advokatfirman Lindahl KB has experience advising on licensing, capital markets issues, and broader commercial matters. Based in Uppsala, practice head Hugo Norlén provides expertise in IP matters and is frequently engaged by academic bodies. Mikael Smedeby is a key name for corporate issues.

Praxisleiter:

Hugo Norlén


Weitere Kernanwälte:

Mikael Smedeby; Patrik Rindståhl


Referenzen

‘Excellent team led by Patrik Rindståhl. High-quality advice on various topics, fast and very supportive. ’

‘Experienced, knowledgeable and efficient.’

‘Top-notch law firm. Experience and breadth in transactional work (licensing and collaborations), regulatory, litigation, and securities. Practical and wise.’

Kernmandanten

Affibody AB


Akiram Therapeutics AB


Alder Therapeutics AB


Amferia AB


AMRA Medical AB


Antaros Medical AB


BioArctic AB (publ)


BioLamina AB


Dilafor AB


Egetis Therapeutics AB (publ)


Intrance Medical Systems Inc


Medivir AB (publ)


Mesenkia Therapeutics AB


Miris AB


Nanexa AB (publ)


Nanologica AB (publ)


Navinci Diagnostics AB


NeoDynamics AB (publ)


Orexo AB (publ)


Palette Life Sciences AB


Philips AB, Personal Heath


Q-linea AB (publ)


Salipro Biotech AB


Senzime AB (publ)


Stardots AB


ThermoFisher Scientific


Phadia AB


Vitrolife AB (publ)


Highlight-Mandate


  • Advised Antaros Holding AB and its shareholders on Lauxera Capital Partners‘ investment.
  • Advised Dicot Pharma AB on its oversubscribed rights issue of units to finance the clinical phase 2a trial for the erectile dysfunction drug candidate LIB-01, including prospectus preparation and corporate documentation.
  • Advised Mesenkia Therapeutics AB on a worldwide exclusive license agreement with University of Tokyo, Yamaguchi University, and RIKEN for proprietary technology to develop novel therapeutic agents targeting glioblastoma brain tumours.

Magnusson

The team at Magnusson remains active, advising on a range of regulatory and commercial mandates, including on public procurement and data privacy matters. The group has particular experience advising clients on commercial relations in the public sector. Practice head Morvarid Dorkhan Nilsson has experience advising on medical devices and pharmaceutical advertising. Helena Rönqvist is a key contact for IP mandates, and Wille Steinert is well regarded for his work on localising global governance programmes.

Praxisleiter:

Morvarid Dorkhan Nilsson


Weitere Kernanwälte:

Wille Steinert; Helena Rönqvist


Referenzen

‘The team stands out through its strong expertise in the healthcare and life science practice, its ability to deliver on promises, and its capacity to handle even highly complex matters in a structured and solution-oriented way.‘

‚What makes this practice unique is the combination of deep industry knowledge, a consultative approach, and a genuine commitment to understanding the client’s needs.‘

‘The individuals I work with consistently stand out through their ability to deliver exactly what they promise, on time, and backed by a high level of legal expertise.‘

Kernmandanten

Becton Dickinson Sweden Aktiebolag


Feelgood Företagshälsovård AB


Histolab Products Aktiebolag


Kungshusen Medicinska AB


Mediq Sverige AB


Oy Becton Dickinson


Quanterix Corporation


Sia Metfarm


Sverek AB


Théa Laboratories


Highlight-Mandate


  • Represented Becton Dickinson in court proceedings in a high-profile case acknowledged by Swedish industry associations in healthcare and life sciences concerning a public procurement potentially violating the MDR regulations on intended use and manufacturer liability for safe products.
  • Representing Laboratoires Théa, appealing a decision from the Swedish Medical Products Agency regarding the substitutability of drugs and the interpretation of the complex legal prerequisites of pharmaceutical equivalence.
  • Represented a Medtech company in resolving a contractual dispute where a sophisticated tripartite solution enabled a third party to undercut and bypass the client.

Roschier

Roschier‘s life sciences and health care offering adeptly handles a range of patent litigations and private equity transactions within the sector. Erik Ficks heads the group, where he has experience in regulatory matters and public procurement- he is also often engaged by pharma companies for these mandates. Björn Johansson Heigis works alongside him and is a key contact within the group for information technology-related matters, including MedTech.

Praxisleiter:

Erik Ficks


Weitere Kernanwälte:

Björn Johansson Heigis


Referenzen

‘The team is very skilled, and are able to help the customer, according to their needs and strategy.’

‘Their ability to understand our needs, and execute that diligently, to deliver the value we want to achieve.’

Kernmandanten

Neurim Pharmaceuticals


Philip Morris International


Highlight-Mandate


  • Representing Neurim Pharmaceuticals in a multi-jurisdictional pharma patent case.
  • Representing KKR and RWK BidCo in their SEK 11.6 billion public offer for Biotage AB (publ).
  • Representing Investor AB on the acquisition by Advanced Instruments of Nova Biomedical for USD 2.2 billion.

Westerberg & Partners

Specialising in intellectual property matters within the life sciences sector, the team at Westerberg & Partners remains active, advising a range of pharma and healthcare companies. Jonas Löfgren heads the group, where he has extensive experience in market access, compliance, and agreement drafting within the sector. Ludvig Holm is another notable name within the team, being a key contact for patent litigation and wider trademark mandates. Björn Rundblom Andersson is well placed to handle trade secrets and license agreements disputes.

Praxisleiter:

Jonas Löfgren


Weitere Kernanwälte:

Björn Rundblom Andersson; Ludvig Holm


Kernmandanten

Alnylam Pharmaceuticals


Novartis


Dr. Wolff Group


Karo Pharma


Permobil Group


Highlight-Mandate


  • Advised Dr. Wolf Group on the market access in Sweden of its first medicinal product, Axhidrox
  • Advising Karo Pharma Group subsidiaries Karo Healthcare and CCS Skincare brands in the Swedish Patent & Market Court against a claim from Footmender AB that the claims used for promoting the products are medical and thus would require a classification as a medicinal product or medical device of the products.

DLA Piper Sweden

Working on a diverse range of IP, private equity, and competition mandates, the team at DLA Piper Sweden continues to advise pharma companies, healthcare providers, and health organisations. Jointly leading the practice, Peder Grandinson is noted for his work in equity capital market transactions. Fellow co-head Charlotte Brunlid is regarded for her public procurement work, while Beatrice Rist is a key name, advising on regulatory considerations. Former team head Fredrika Allard left the practice in June 2025.

Praxisleiter:

Peder Grandinson; Charlotte Brunlid


Weitere Kernanwälte:

Beatrice Rist


Referenzen

‘They have excellent expertise, a network with diverse experiences, and they are responsive to the customer’s needs and views.’

‘Excellent service, pragmatic approach, and superb client attention.’

‘I’ve worked with Charlotte Brunlid. Her uniqueness lies in her depth in public procurement, complex agreements, and a pragmatic, solution-based approach. She also brings great joy, enthusiasm, and energy to all and every meeting.’

Kernmandanten

Apotekstjänst Sverige AB


Attendo


Lightspeed Venture Partners


Kommunalförbundet Skandionkliniken


SynAct Pharma AB (publ)


Bergman Clinics


Highlight-Mandate


  • Advising Kommunalförbundet Skandionkliniken (the Skandion clinic) with its public procurement of a supplier for the operation and maintenance of its proton therapy system.
  • Advised ITB-Med on various data protection aspects, including such related to clinical trials.
  • Advised Bergman Clinics on its acquisition of Nordiska Kliniken.

CMS Wistrand

CMS Wistrand provides a comprehensive life sciences and healthcare offering, including advising on corporate mandates, regulatory compliance matters, and financing. Mattias Boqvist, who jointly leads the team, has considerable experience in a range of M&A transactions and commercial contract matters. Fellow practice head Niclas Widjeskog is a key name for clients requiring representation in dispute resolution issues and advising on regulatory matters.

Praxisleiter:

Niclas Widjeskog; Mattias Boqvist


Referenzen

‘Very responsive and deep understanding.‘

Highlight-Mandate


Synch Law AB

Offering an interdisciplinary approach, Synch Law AB advises on a range of intellectual property, corporate, and capital market issues. The group has a strong cross-border offering, supporting clients in a range of contentious and non-contentious matters. Mathilda Nordmark is a key contact for patent matters, and Sara Sparring is regarded for her work on trademarks and copyright issues. Nordmark and Sparring jointly lead the group.

Praxisleiter:

Mathilda Nordmark; Sara Sparring


Referenzen

‘Synch holds a great knowledge within the healthcare and life science sector, both a local Swedish perspective, but also linked to international commercial aspects of the industry.’

‘Sara Sparring has a deep knowledge of commercial aspects of the healthcare and life science sector.’

‘The team is well equipped with a wide range of specialities.’

Kernmandanten

Tandem Health


Apotek Produktion och Laboratorier AB


Innovestor Life Science Fund


Hadean Ventures


KRKA, d. d., Novo mesto


AlzeCure Pharma AB


PolarVentures


Hale Breathing in Stockholm AB


Stroller AB


Attana AB


Tandem Health


Apotek Produktion och Laboratorier AB


Innovestor Life Science Fund


Hadean Ventures


KRKA, d. d., Novo mesto


AlzeCure Pharma AB


PolarVentures


Hale Breathing in Stockholm AB


Stroller AB


Attana AB


Highlight-Mandate


  • Advising Tandem Health in connection with its recent USD 50m equity financing round, led by Kinnevik, with participation from Northzone, Amino Collective, and Visionaries Club.
  • Advising Apotek Produktion & Laboratorier AB (APL) in connection with its SEK 700 million acquisition of a penicillin manufacturing facility from UK-headquartered Meribel Pharma Solutions.
  • Advising Innovestor Life Science Fund and Hadean Ventures in connection with their investment in Gesynta Pharma.

TM & Partners

TM & Partners‘ life sciences and health care offering involves capital market issues, labour and employment matters, as well as data privacy and protection mandates. Fredrik Gustafsson offers expertise in data protection in cross-border deals, and Anna Jerndorf brings extensive experience in labour and employment matters. They both lead the practice alongside Johan Wigh, noted for his equity capital markets work.

Praxisleiter:

Fredrik Gustafsson; Anna Jerndorf; Johan Wigh


Referenzen

‘Hands on. High availability. Solution-oriented. Small and efficient teams.‘

‚Good relationship with relevant regulatory authorities.’

Kernmandanten

Apoteket


Coala-Life Group AB


Otsuka Pharma Europe


Swemac


Team Olivia Group


Vivesto AB


Scan Sverige


Lantmännen ek för


Färna Invest


Highlight-Mandate


  • Assisted Scan Sverige AB, part of Lantmännen since spring of 2024, in connection with the acquisition of all shares in Lindvalls Chark AB.
  • Advised Healthy to 100 AS in connection with the reverse takeover of eBlitz Group AB (publ) (currently H100 Group AB) and the continued listing of H100 Group AB’s shares on Nordic Growth Market’s list Nordic SME.
  • Advised Redo Biosolutions AS, a joint venture between Air Liquide S.A. and Skagerak Energi AS, on the acquisition of Redo Sävsjö AB.